Company
Syantra
Onco-ID™ – a patent-pending cancer detection platform — doesn’t look for cancer cells directly, but instead focuses on detecting shifts in normal body systems to tell us when something is going wrong.
Also known as Syantra Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Calgary, Alberta, Canada
- Legal name
- Syantra Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Where most liquid biopsies and molecular tests look for specific components of cancer cells (or cancer cells themselves) in the bloodstream after cancer is already established, Syantra captures and decodes much earlier changes in how the body is functioning, and whether a cancer is likely becoming established.
Products
- Other
- Onco-ID
- Other
- Syantra DX Breast Cancer test
Loading relationship preview